Literature DB >> 11122025

Changing trends in non-melanoma skin cancer in South Wales, 1988-98.

S A Holme1, K Malinovszky, D L Roberts.   

Abstract

BACKGROUND: In 1988 our department carried out a population-based epidemiological study of non-melanoma skin cancer (NMSC) incidence, over a 6-month period, in West Glamorgan, South Wales. Objectives To reassess the incidence of NMSC in this defined population over a similar 6-month period 10 years after the initial study.
METHODS: All cases of basal cell carcinoma and squamous cell carcinoma diagnosed in West Glamorgan are recorded by the local skin cancer registry. All cases for the relevant 6-month period were analysed.
RESULTS: Using these figures, we have identified a significant rise in the crude incidence of NMSC from 173.5 10 years ago to 265.4 per 100,000 population per annum. We also applied the world standard population for age to our crude figures, demonstrating a combined male and female world population-corrected rate of 129.9 per 100,000 population.
CONCLUSIONS: In our population the crude incidence of NMSC has risen significantly over 10 years. Additionally, the combined male and female world population-corrected rate appears to be the highest published standardized incidence of NMSC to date from any European country.

Entities:  

Mesh:

Year:  2000        PMID: 11122025     DOI: 10.1046/j.1365-2133.2000.03892.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  21 in total

Review 1.  Basal cell carcinoma.

Authors:  C S M Wong; R C Strange; J T Lear
Journal:  BMJ       Date:  2003-10-04

2.  'The Health of the Nation'--an unattainable skin cancer target predictably remains beyond reach.

Authors:  Neil H Cox
Journal:  J R Soc Med       Date:  2009-05       Impact factor: 5.344

Review 3.  Skin cancer - an overview for dentists.

Authors:  B J Steel
Journal:  Br Dent J       Date:  2014-05       Impact factor: 1.626

4.  CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas.

Authors:  Blanche Ka Ki Lo; Mei Yu; David Zloty; Bryce Cowan; Jerry Shapiro; Kevin John McElwee
Journal:  Am J Pathol       Date:  2010-03-12       Impact factor: 4.307

5.  A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics.

Authors:  Sharifeh Farasat; Siegrid S Yu; Victor A Neel; Kishwer S Nehal; Thomas Lardaro; Martin C Mihm; David R Byrd; Charles M Balch; Joseph A Califano; Alice Y Chuang; William H Sharfman; Jatin P Shah; Paul Nghiem; Clark C Otley; Anthony P Tufaro; Timothy M Johnson; Arthur J Sober; Nanette J Liégeois
Journal:  J Am Acad Dermatol       Date:  2011-01-20       Impact factor: 11.527

6.  Vismodegib (erivedge) for advanced Basal cell carcinoma.

Authors:  Chris Fellner
Journal:  P T       Date:  2012-12

7.  Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation.

Authors:  Jeffrey L Schwartz; Kenneth J Kopecky; Robert W Mathes; Wendy M Leisenring; Debra L Friedman; H Joachim Deeg
Journal:  Radiat Res       Date:  2009-02       Impact factor: 2.841

8.  Scalp Lesions Referred For Surgical Procedures: Single-Center 5-year Experience in Southwestern Poland.

Authors:  Iwona Chlebicka; Aleksandra A Stefaniak; Anna Gawdzik; Alicja RygaŁ; Łukasz Matusiak; Jacek C Szepietowski
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

9.  Clinical and histopathologic characteristics of skin malignancies in Qassim Region, Saudi Arabia.

Authors:  Abdullateef A Alzolibani; Hani A Al Shobaili; Ahmad Al Robaee; Athar Khan; Imran Ul Haque; Nagendra Seethapathi Rao; Abdulaziz Alrejaie
Journal:  Int J Health Sci (Qassim)       Date:  2013-01

10.  [Skin cancer and occupational disease].

Authors:  T L Diepgen; H Drexler
Journal:  Hautarzt       Date:  2004-01       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.